Form 4: CME Group Executive Jack J. Tobin Reports Share Transactions

Jack J. Tobin, MD Chief Accounting Officer of CME Group Inc., reports acquisition and disposal of company shares to cover tax obligations and from performance share awards.

Summary

• On March 15, 2024, Jack J. Tobin, MD Chief Accounting Officer of CME Group Inc., reported transactions involving CME Group Class A Common Stock.
• Tobin acquired 541 shares from a 2020 performance share award based on the company's total shareholder return relative to the S&P 500 over 2021-2023, priced at $217.5 per share.
• He also disposed of 159 shares and 479 shares to fulfill tax withholding obligations related to the performance share award and the vesting of restricted stock, respectively, both priced at $217.5 per share.
• Following these transactions, Tobin beneficially owns 22,965 shares of CME Group Class A Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing primarily reports routine transactions related to executive compensation and tax obligations. There are no explicit positive or negative implications for the company's performance.

Positives

• The acquisition of shares from the performance share award indicates that the company met its total shareholder return targets relative to the S&P 500 over the 2021-2023 period.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the United States, ensuring transparency in insider trading activities.
• The transactions reported are typical for executives receiving stock-based compensation and managing their tax obligations.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.

Key Dates